Almond Intervention in Type 2 Diabetes Mellitus
Not Applicable
Completed
- Conditions
- Cardiovascular Diseases
- Interventions
- Dietary Supplement: almond
- Registration Number
- NCT02027740
- Lead Sponsor
- Diabetes Foundation, India
- Brief Summary
This prospective cohort study of an almond-enriched diet (within the overall context of Asian Indian dietary guidelines) was conducted to test the hypothesis that in patients with T2DM almond-enriched balanced diet improves glycemic measures and CVD risk factors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Patients in the age range of 25-65 years
- on stable doses of metformin from past 3 months
- having HbA1C less than 9%
- LDL-c ≥100 mg/dl were recruited
Exclusion Criteria
- Patients on insulin therapy, plioglitazone, insulin secretagogues, beta blockers or steroids or suffering from diabetes for more than 10 years
- having high uric acid levels (≥ 8 mg/dl),
- with accelerated hypertension (stage 2 hypertension according to JNC guidelines) , hypothyroidism, suffering from acute infection or any debilitating disease or with renal failure,
- appreciable weight loss (more than 10%) during past 6 months
- Patients with known food allergy, lipid altering medication or extraneous factors that can affect glycemic or lipid parameters
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description almond almond almonds are substituted for visible fat and carbohydrates
- Primary Outcome Measures
Name Time Method Change in LDL-c baseline, after six months
- Secondary Outcome Measures
Name Time Method HbA1C baseline, after six months of intervention
Trial Locations
- Locations (1)
Fortis Flt Lt Hospital
🇮🇳Delhi, India